Dogwood Therapeutics DWTX Cash Flow Statement
| TTM Q1 '26 | TTM Q4 '25 | TTM Q3 '25 | TTM Q2 '25 | TTM Q1 '25 | ||
|---|---|---|---|---|---|---|
| -$28.32M+17.3% | -$34.26M+10.3% | -$38.2M-54.4% | -$24.74M-12.5% | -$21.98M-78.0% | ||
| —— | —— | —— | $40.37K+54.3% | $26.15K+115% | ||
| $720.59K+103% | $355.64K+22.0% | $291.58K-13.6% | $337.61K-19.9% | $421.53K-11.4% | ||
| -$15.52M+0.6% | -$15.62M+13.8% | -$18.11M-15.0% | -$15.75M-25.6% | -$12.54M-42.6% | ||
| —— | —— | —— | —— | —— | ||
| —— | —— | —— | —— | —— | ||
| —— | —— | —— | —— | —— | ||
| -$4.32M+48.2% | -$8.33M-201% | $8.22M-21.8% | $10.52M-31.3% | $15.3M+31.1% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How much cash does Dogwood Therapeutics generate?
- Dogwood Therapeutics (DWTX) generated -$15.5M in operating cash flow over the trailing twelve months.
- Where does Dogwood Therapeutics's cash flow data come from?
- Every line is extracted from Dogwood Therapeutics's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.